Skip to content

Clinical trials

Neoplasms trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Country / region: Serbia Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20093
20112
20135
20151
20161
20173
20192
20203
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated7
Active, not recruiting6
Recruiting3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie5
Hoffmann-La Roche5
Grünenthal GmbH2
Tris Pharma, Inc.2
Amgen1
Bayer1
Biocon Biologics UK PLC1
Centus Biotherapeutics Limited1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms30
Carcinoma, Non-Small-Cell Lung7
Pain4
Cancer Pain3
Chronic Pain3
Lung Neoplasms3
Neoplasm Metastasis3
Primary Myelofibrosis3
Colorectal Neoplasms2
Gastrointestinal Neoplasms2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.